DK2964193T3 - Lægemidler til oral indgivelse - Google Patents
Lægemidler til oral indgivelse Download PDFInfo
- Publication number
- DK2964193T3 DK2964193T3 DK14714013.1T DK14714013T DK2964193T3 DK 2964193 T3 DK2964193 T3 DK 2964193T3 DK 14714013 T DK14714013 T DK 14714013T DK 2964193 T3 DK2964193 T3 DK 2964193T3
- Authority
- DK
- Denmark
- Prior art keywords
- oral administration
- administration drugs
- drugs
- oral
- administration
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361772927P | 2013-03-05 | 2013-03-05 | |
| US201461925443P | 2014-01-09 | 2014-01-09 | |
| PCT/US2014/020763 WO2014138241A1 (en) | 2013-03-05 | 2014-03-05 | Pharmaceuticals for oral delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2964193T3 true DK2964193T3 (da) | 2020-03-16 |
Family
ID=50391422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14714013.1T DK2964193T3 (da) | 2013-03-05 | 2014-03-05 | Lægemidler til oral indgivelse |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US9457086B2 (da) |
| EP (1) | EP2964193B1 (da) |
| JP (1) | JP6375314B2 (da) |
| CN (1) | CN105101950B (da) |
| AU (3) | AU2014225822B2 (da) |
| CA (1) | CA2904327C (da) |
| DK (1) | DK2964193T3 (da) |
| ES (1) | ES2774962T3 (da) |
| IL (1) | IL240666A0 (da) |
| WO (1) | WO2014138241A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050282756A1 (en) | 2004-06-18 | 2005-12-22 | Mehta Nozer M | Oral delivery of peptide pharmaceutical compositions |
| US8377863B2 (en) | 2007-05-29 | 2013-02-19 | Unigene Laboratories Inc. | Peptide pharmaceutical for oral delivery |
| US9457086B2 (en) | 2013-03-05 | 2016-10-04 | Enteris Biopharma, Inc. | Pharmaceuticals for oral delivery |
| US9833411B2 (en) | 2015-01-12 | 2017-12-05 | Enteris Biopharma, Inc. | Solid oral dosage forms |
| JP2023511439A (ja) | 2020-01-28 | 2023-03-17 | ジェネンテック, インコーポレイテッド | がんの治療のためのil15/il15rアルファヘテロ二量体fc融合タンパク質 |
| CN119630685A (zh) | 2022-06-13 | 2025-03-14 | B.A.I.实验室有限责任公司 | 结合白介素-13的环状寡肽及其使用方法 |
| WO2025240494A1 (en) | 2024-05-13 | 2025-11-20 | Lumen Bioscience, Inc. | Leptin compositions and methods of making and using the same to support weight loss and/or maintenance |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2956926A (en) * | 1958-09-23 | 1960-10-18 | American Cyanamid Co | Coated citric acid particles |
| NZ196348A (en) * | 1980-03-07 | 1984-08-24 | Interx Research Corp | Enhancement of absorption rate of orally administered antibiotics |
| JPS57146723A (en) * | 1981-03-06 | 1982-09-10 | Toyo Jozo Co Ltd | Pharmaceutical preparation having improved absorption |
| US4537772A (en) * | 1984-05-02 | 1985-08-27 | Merck & Co., Inc. | Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines |
| US5789234A (en) | 1987-08-14 | 1998-08-04 | Unigene Laboratories, Inc. | Expression systems for amidating enzyme |
| US5912014A (en) | 1996-03-15 | 1999-06-15 | Unigene Laboratories, Inc. | Oral salmon calcitonin pharmaceutical products |
| EP1005526B1 (en) | 1997-04-16 | 2010-10-13 | Unigene Laboratories, Inc. | Direct expression of peptides into culture media |
| CN1183965C (zh) | 2000-02-04 | 2005-01-12 | 尤尼金实验室公司 | 鼻内降钙素制剂 |
| US6673574B2 (en) | 2000-11-30 | 2004-01-06 | Unigene Laboratories Inc. | Oral delivery of peptides using enzyme-cleavable membrane translocators |
| US7316819B2 (en) | 2001-03-08 | 2008-01-08 | Unigene Laboratories, Inc. | Oral peptide pharmaceutical dosage form and method of production |
| WO2002087621A1 (en) * | 2001-04-30 | 2002-11-07 | Shire Laboratories Inc. | Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers |
| US8088734B2 (en) | 2003-01-21 | 2012-01-03 | Unigene Laboratories Inc. | Oral delivery of peptides |
| US20050215476A1 (en) * | 2004-01-21 | 2005-09-29 | Unigene Laboratories Inc. | Amidated parathyroid hormone fragments and uses thereof |
| US8227241B2 (en) | 2004-03-12 | 2012-07-24 | Unigene Laboratories, Inc. | Bacterial host cell for the direct expression of peptides |
| KR20050104152A (ko) | 2004-04-28 | 2005-11-02 | 최승호 | 경구용 약물의 흡수를 증진하는 약제학적 조성물 |
| US20050282756A1 (en) | 2004-06-18 | 2005-12-22 | Mehta Nozer M | Oral delivery of peptide pharmaceutical compositions |
| WO2006026592A2 (en) | 2004-08-27 | 2006-03-09 | Spherics, Inc. | Oral administration of poorly absorbed drugs, methods and compositions related thereto |
| US7445911B2 (en) | 2004-11-24 | 2008-11-04 | Unigene Laboratories Inc. | Enzymatic reactions in the presence of keto acids |
| DK1907561T3 (da) | 2005-06-24 | 2013-12-02 | Enteris Biopharma Inc | Cellelinjer til ekspression af enzym, der er anvendeligt i fremstillingen af amiderede produkter |
| US7449896B2 (en) * | 2005-07-29 | 2008-11-11 | Ixys Corporation | Current sensor using level shift circuit |
| US8093207B2 (en) | 2005-12-09 | 2012-01-10 | Unigene Laboratories, Inc. | Fast-acting oral peptide pharmaceutical products |
| EP1964566A4 (en) * | 2005-12-22 | 2009-01-07 | Asubio Pharma Co Ltd | PREPARATION HAVING IMPROVED BIOABSORPTION CAPACITY OF SAPROPTERIN CHLORHYDRATE |
| KR20080085184A (ko) * | 2005-12-22 | 2008-09-23 | 와이어쓰 | 티게사이클린을 사용한 위장관 감염의 치료방법 |
| AR060355A1 (es) * | 2007-04-04 | 2008-06-11 | Kelly Jose Luis | Aparato para disipar el agua producida por equipos de climatizacion |
| US8377863B2 (en) | 2007-05-29 | 2013-02-19 | Unigene Laboratories Inc. | Peptide pharmaceutical for oral delivery |
| CN102014878B (zh) * | 2007-11-05 | 2013-10-23 | 夏威夷大学 | 用于口服给药极性药剂的提高生物利用度的制剂 |
| US20100256060A1 (en) * | 2009-04-02 | 2010-10-07 | Unigene Laboratories Inc. | Peptide pharmaceuticals for nasal delivery |
| US20120071410A1 (en) | 2010-09-21 | 2012-03-22 | Unigene Laboratories Inc. | Calcitonin products and therapies for treating inflammatory or degenerative diseases |
| MX345501B (es) | 2010-12-16 | 2017-02-02 | Novo Nordisk As | Composiciones solidas que comprenden agonista de glp-1 y sal del acido n-(8-(2-hidroxibenzoil)amino)caprilico. |
| CA2839408A1 (en) * | 2011-06-14 | 2012-12-20 | Stealth Peptides International, Inc. | Aromatic-cationic peptides and uses of same |
| HUE042929T2 (hu) | 2011-06-15 | 2019-07-29 | Resother Pharma Aps | Gyulladáscsökkentõ gyógyszerészeti termékek |
| US9457086B2 (en) | 2013-03-05 | 2016-10-04 | Enteris Biopharma, Inc. | Pharmaceuticals for oral delivery |
| US9833411B2 (en) | 2015-01-12 | 2017-12-05 | Enteris Biopharma, Inc. | Solid oral dosage forms |
-
2014
- 2014-03-05 US US14/197,405 patent/US9457086B2/en active Active
- 2014-03-05 EP EP14714013.1A patent/EP2964193B1/en active Active
- 2014-03-05 WO PCT/US2014/020763 patent/WO2014138241A1/en not_active Ceased
- 2014-03-05 AU AU2014225822A patent/AU2014225822B2/en active Active
- 2014-03-05 JP JP2015561608A patent/JP6375314B2/ja active Active
- 2014-03-05 DK DK14714013.1T patent/DK2964193T3/da active
- 2014-03-05 CN CN201480020438.4A patent/CN105101950B/zh active Active
- 2014-03-05 ES ES14714013T patent/ES2774962T3/es active Active
- 2014-03-05 CA CA2904327A patent/CA2904327C/en active Active
-
2015
- 2015-08-18 IL IL240666A patent/IL240666A0/en active IP Right Grant
-
2016
- 2016-06-16 US US15/184,971 patent/US9526785B2/en active Active
- 2016-11-16 US US15/353,213 patent/US9744140B2/en active Active
-
2017
- 2017-05-02 AU AU2017202900A patent/AU2017202900B2/en active Active
- 2017-07-21 US US15/656,142 patent/US20170319502A1/en not_active Abandoned
-
2018
- 2018-07-17 AU AU2018206721A patent/AU2018206721B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2964193B1 (en) | 2019-12-11 |
| US20170319502A1 (en) | 2017-11-09 |
| IL240666A0 (en) | 2015-10-29 |
| JP6375314B2 (ja) | 2018-08-15 |
| CA2904327C (en) | 2021-06-08 |
| US20170056328A1 (en) | 2017-03-02 |
| CN105101950A (zh) | 2015-11-25 |
| ES2774962T3 (es) | 2020-07-23 |
| AU2017202900A1 (en) | 2017-06-01 |
| EP2964193A1 (en) | 2016-01-13 |
| CN105101950B (zh) | 2019-10-11 |
| US9744140B2 (en) | 2017-08-29 |
| AU2014225822A1 (en) | 2015-09-03 |
| AU2017202900B2 (en) | 2018-04-26 |
| US9526785B2 (en) | 2016-12-27 |
| US9457086B2 (en) | 2016-10-04 |
| AU2018206721B2 (en) | 2019-07-11 |
| CA2904327A1 (en) | 2014-09-12 |
| US20140255479A1 (en) | 2014-09-11 |
| AU2018206721A1 (en) | 2018-08-09 |
| WO2014138241A1 (en) | 2014-09-12 |
| AU2014225822B2 (en) | 2017-05-04 |
| US20160296624A1 (en) | 2016-10-13 |
| JP2016510747A (ja) | 2016-04-11 |
| HK1216082A1 (zh) | 2016-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3062849T3 (da) | Medikamentadministrationsanordning | |
| DK3639872T3 (da) | Lægemiddeladministrationsanordning | |
| DK2983721T4 (da) | Terapeutiske indgivelsesvesikler | |
| DK3030262T3 (da) | Kombineret farmaceutisk sammensætning | |
| BR112016009485A2 (pt) | Inalador de medicamento | |
| DK3669913T3 (da) | Anordning til indgivelse af lægemidler | |
| DK3287133T3 (da) | Proton-bindende polymerer til oral indgivelse | |
| IL240797B (en) | Oral formulations of deferasirox | |
| DK3099356T3 (da) | Medikamentadministrationsanordning | |
| DK2970389T3 (da) | Farmaceutiske forbindelser | |
| EP2953618A4 (en) | MANIPULATION-SAFE PHARMACEUTICAL FORMULATIONS | |
| DK3038674T3 (da) | Medikamentafgivelsesindretning | |
| DK3380139T3 (da) | Medikamentadministrationsanordning | |
| DK3380146T3 (da) | Medikamentadministrationsanordning | |
| DK3071268T3 (da) | Indretning til en lægemiddeladministrationsanordning | |
| ZA201507576B (en) | Pharmaceutical combination drug | |
| DK3590499T3 (da) | Inhalerbare lægemidler | |
| DK3021911T3 (da) | Anordning til indgivelse af lægemidler | |
| DK2968780T3 (da) | Indretning til en lægemiddeladministrationsanordning | |
| DK2964193T3 (da) | Lægemidler til oral indgivelse | |
| DK3071265T3 (da) | Fjederassisteret lægemiddeladministrationsanordning | |
| DK3041546T3 (da) | Indretning til en lægemiddeladministrationsanordning | |
| DK3349825T3 (da) | Lægemiddeladministrationsanordning | |
| DK3043845T3 (da) | Lægemiddelfremføringsanordning | |
| DK3349827T3 (da) | Lægemiddeladministrationsanordning |